Pfizer announced yesterday that a third shot of its COVID-19 vaccine boosts immune protection in children ages 5 years to 11 years.
strong immune response findings in children down to 6 months of age from a two-dose series of its vaccine. Moderna has also requested FDA authorization for younger children to receive its vaccine.
The Pfizer COVID-19 vaccine for children 5 through 11 differs from the one being used in people 12 years of age and older, and the two should not be used interchangeably, the company said.Pfizer: “Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age.”
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Pfizer says its booster shot strengthens immune response for ages 5-11A booster shot of the coronavirus vaccine made by Pfizer-BioNTech increased the level of neutralizing antibodies against both the original version of the virus and the omicron variant in a small trial of children age 5 to 11, the companies said.
続きを読む »
Pfizer says booster in children 5-11 raises antibodies against omicronThe company says it plans to submit its data to the FDA for authorization.
続きを読む »
Pfizer to seek COVID booster for healthy 5- to 11-year-oldsPfizer wants to expand its COVID-19 booster shots to healthy 5- to 11-year-olds.
続きを読む »
Covid booster shot bolsters protection in 5-to-11-year-olds, Pfizer and BioNTech sayThe third shot appears to broaden the ability of the immune system to recognize variants such as omicron.
続きを読む »
Pfizer to seek COVID booster for healthy 5- to 11-year-oldsNEW: Pfizer says it wants to expand its COVID-19 booster shots to healthy elementary-age kids.
続きを読む »
Pfizer aims to expand COVID booster shot to healthy kids ages 5 to 11Pfizer says new data shows healthy 5- to 11-year-olds could benefit from another kid-sized COVID-19 shot.
続きを読む »